Amylin Pharmaceuticals' IPO

Amylin Pharmaceuticals raised a round of funding on January 17, 1992. Investors include Public.

Amylin Pharmaceuticals is engaged in the discovery and development of potential drug candidates for the treatment of metabolic disorders. The Company is developing SYMLIN for the treatment of people w…

Articles about Amylin Pharmaceuticals' IPO: